Clinical Use of Point-of-Care High-Sensitivity Cardiac Troponin for Early Diagnosis of Myocardial Infarction

This webinar was recorded live on June 25, 2024.
It is available on demand through June 30, 2025.
Register above for access

Description

Current clinical practice guidelines recommend the use of diagnostic clinical pathways incorporating high-sensitivity cardiac troponin (hs-cTn) measurements. This recommendation is based on large diagnostic and interventional studies using nearly exclusively central-laboratory platforms. In contrast to central-laboratory based hs-cTn assays, point-of-care (POC) assays would allow early diagnosis of myocardial infarction (MI) to be further accelerated by reducing the time from blood draw to clinical decision making, as they obviate the need for sample transportation and centrifugation. While former POC assays did not fulfill the analytical criteria of hs-cTn assays, newer assays seem to have overcome these limitations and shown promising results.

In this webinar, the speaker, Dr. Luca Koechlin, will give a detailed overview about the current knowledge of high-sensitivity cardiac troponin assays in the early diagnosis of myocardial infarction with a special focus on the novel Point-of-Care hs-cTn assays and their clinical use.

Target Audience

This activity is designed for physicians, advanced practice professionals (NPs, PAs, RNs, etc.) lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, point-of-care coordinators, pathologists, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.

Learning Objectives

At the end of this session, participants will be able to:

• Recognize the importance of hs-cTn assays for the early diagnosis of myocardial infarction.
• Identify new possibilities when using Point-of-Care hs-cTn assays instead of central-laboratory based assays.
• Recall the latest evidence for Point-of-Care hs-cTn assays for the early diagnosis of myocardial infarction.

Faculty

Luca Koechlin, MD
Consultant, Department of Cardiac Surgery
Senior Research Fellow, Cardiovascular Research Institute Basel (CRIB)
University Hospital Basel
Basel, Switzerland

Disclosures and Statement of Independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported financial relationships:

• Luca Koechlin, MD
  • Honorarium/Expenses: Polymedco, Roche Diagnostics, Abbott, Siemens Healthineers
  • Grant/Research Support: Swiss Heart Foundation, the University of Basel, the Swiss Academy of Medical Sciences and the Gottfried, Julia Bangerter-Rhyner Foundation, Freiwillige Akademische Gesellschaft Basel

Content Validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation Statement

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID #4305. This activity was planned in accordance with ACCENT® Standards and Policies.

Successful Completion Statement

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org.